This week we highlight potential new medtech regulations in the UK, challenges facing CAR-T therapies and another CRISPR-based gene therapy approval. We also examine the multi-faceted approach being taken by biotech companies seeking funding or potential exits. Additionally, we look at a new device for ... READ MORE >
medtech
5 things to know in life sciences: Week of Jan. 8, 2024
This week we highlight the integration of artificial intelligence in regulatory compliance for software as a medical device (SaMD), alongside a surge in health care mergers and acquisitions totaling over $6.4 billion. We also examine the U.S. Food and Drug Administration’s approval of Florida's drug ... READ MORE >
5 things to know in life sciences: Week of Dec. 18, 2023
This week we highlight a potential U.S. Food and Drug Administration subpoena amid a probe into overseas inspections. We also look at a divestiture of an early cancer-detection company following a Federal Trade Commission challenge. Additionally, we explore the approval of the first DNA test to identify ... READ MORE >
5 things to know in life sciences: Week of Dec. 11, 2023
This week we highlight a year-end review of private biopharma financing. We also look at a plan by the federal government to potentially seize patents on certain high-cost drugs. Additionally, we explore a breakthrough in treatment of sickle cell disease, the growing impact of counterfeit drugs on the ... READ MORE >
5 things to know in life sciences: Week of Dec. 4, 2023
This week we highlight the increasing importance of environmental, social and governance (ESG) initiatives in the Asia Pacific medtech sector, as well as the potential of semaglutide, a diabetes and weight loss medication, in treating alcohol use disorder. We also look at the pharmaceutical industry's ... READ MORE >
5 things to know in life sciences: Week of Nov. 27, 2023
This week we highlight a new diagnostic device for detecting traumatic brain injury and the U.S. Food and Drug Administration’s investigation into the risk of patients developing new cancers after receiving CAR-T cell immunotherapies. We also look at a new generative artificial intelligence biotech ... READ MORE >
This week’s 5 things to know in life sciences
This week we highlight the challenges related to hepatitis B treatments and the U.S. Food and Drug Administration’s advisory committee meeting regarding timely accelerated approval confirmations. We also look at a new study that highlights COVID-19 rebounds and the exodus of life sciences researchers from ... READ MORE >
5 things to know in life sciences this week
This week we highlight the emergence of Denmark as a major life sciences hub in Europe and the impact of technology on patients, as well as awareness-building on clinical trials. We also look at growth of the life sciences industry in Utah and new legislation in Europe that some say will decrease ... READ MORE >
5 things to know in life sciences: Week of Oct. 30, 2023
This week, we highlight the potential U.S. ban on Apple Watches over patent infringement as well as an analysis of biopharma market cap as it relates to the new U.S. drug price negotiations. We also look at the White House's new artificial intelligence directive aimed to ensure ethical biotech ... READ MORE >
5 things to know in life sciences: Week of Oct. 23, 2023
This week, we highlight Minnesota’s designation as a medtech hub, new developments in medtech in the UK and increased licensing deals in the biopharma sector. Additionally, we spotlight a positive outlook for next year in the life sciences services sector. Lastly, we continue to look at the importance of ... READ MORE >